Symrise, DE000SYM9999

Symrise stock falls 3.49 percent pre-market ahead of the Xetra open

Published on 10/28/2026 at 07:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
3.49 percent below the Xetra close of October 27, 2026 in pre-market trading. At Lang & Schwarz, Symrise stock trades at EUR 96.56 on October 28, 2026.

Pre-market move and company update

  • Symrise stock was 3.49 percent below the October 27, 2026 Xetra close.
  • Symrise reported 5.3 percent organic sales growth in the third quarter on October 28, 2026.
  • Symrise stock trades pre-market at EUR 96.56 at 7:55 a.m. CET at Lang & Schwarz on October 28, 2026, 3.49 percent below the Xetra close of October 27, 2026.
Symrise, DE000SYM9999, Illustration mit AI erstellt.

Symrise stock is 3.49 percent below the Xetra close of October 27, 2026 in pre-market trading. Symrise stock trades pre-market at EUR 96.56 at 7:55 a.m. CET at Lang & Schwarz on October 28, 2026, 3.49 percent below the Xetra close of October 27, 2026 (EUR 100.05).

The indication before Xetra

The indication is EUR 3.49 lower than that reference. The bid is EUR 96.00 and the ask EUR 97.12, a spread of 1.16 percent, indicating thin pre-market trading. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Symrise stock.

Third-quarter growth reported

In a release dated October 28, 2026, Finanzen.ch reported that Symrise achieved 5.3 percent organic sales growth in the third quarter of 2026 and 3.0 percent in the first nine months. Group sales reached EUR 1,310 million in the quarter, compared with EUR 1,222 million a year earlier. Symrise reaffirmed its full-year outlook for organic sales growth of 2 percent to 4 percent, an adjusted EBITDA margin of 21.5 percent to 22.5 percent and an adjusted business free cash flow margin above 14 percent.

Business and the day ahead

Symrise supplies flavors and fragrances, cosmetic base and active ingredients, and functional ingredients to manufacturers in consumer and pharmaceutical markets. Its investor calendar lists the Q3 2026 interim communication for October 28, 2026. Market context: Market report DAX.

More news and analysis on Symrise stock

Disclaimer...
en | DE000SYM9999 | SYMRISE | boerse | 70424448 |